Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) have seen a consistent move higher lately. The stock has reached the $152.96 mark after a recent check. This move has generated increased interest from both analysts and investors.Since the start of the calendar year, Sage Therapeutics, Inc. (NASDAQ:SAGE)’s stock has changed 79.98%. Over the last five trading sessions, the stock has moved -2.39%. For the past month, Sage Therapeutics, Inc.’s stock has been 40.33%, 6.13% for the last quarter, 22.76% for the past six months and 65.05% for the past 52 weeks.
Based on current stock levels, Sage Therapeutics, Inc. shares are trading 52.20% off of the 50-day high and 156.77% away from the 50-day low.
Sage Therapeutics, Inc. (NASDAQ:SAGE)’s EPS growth this year is -39.50% and the trailing 12-month EPS is $-6.87. Covering sell-side analysts are estimating company growth for next year to be -5.00%. On a consensus basis, analysts have given a recommendation of 1.70 on company shares.